Tidbits of Toxicity: Exploring Effects of Ketamine, Psilocybin, and Other Psychedelics

5 (1 vote)

  • Register
    • Non-Member - $39
    • Regular Member - $29
    • Retired - $29
    • Early Career Physician - $29
    • Resident - $19
    • Student - $19
    • Associate - $19
    • ASAM Staff - Free!
    • International Member - $29
    • Emeritus Member - $29
    • Provisional Member - $29
    • Fellow Member - $29
    • Honorary Member - $29
    • CRT Member - $29
Logo for ASAM's 55th Annual Conference

Tidbits of Toxicity: Exploring Effects of Ketamine, Psilocybin, and Other Psychedelics

Recorded: Thursday, April 4, 2024 to Sunday, April 7, 2024
On-Demand Session

Overview

This 75-minute on-demand session from the ASAM 55th Annual Conference addresses the potential beneficial clinical effects, adverse effects and management strategies for patients experiencing toxicity or adverse effects of therapeutic psychoactive agents.

There has been increased interest in the use of ketamine, ibogaine, MDMA, psilocybin, and dimethyltryptamine and harmaline alkaloids for the treatment of psychiatric and substance use disorders. The availability of various forms of these substances both illicitly and in medically directed settings lends importance to understanding the pharmacology, toxicology, and potential for downstream health and societal consequences. This session will summarize the evolving landscape of therapeutic psychoactive agents and highlight rising trends in adverse effects after overdose or therapeutic use.

The target audience for this Intermediate level session includes physicians, nurse practitioners, physician assistants, other clinicians, researchers, residents, fellows, students, and counselors.

This session addresses the following ACGME Competencies: Medical Knowledge, Practice-based Learning and Improvement

This session addresses the following ICPE Competencies:Values and Ethics, Roles and Responsibilities

Learning Objectives

Upon completion, learners will be able to:

  1. Review the pharmacology of therapeutic psychoactive agents: ketamine, ibogaine, MDMA (phenethylamines), psilocybin, and dimethyltryptamine and harmaline alkaloids
  2. Develop a better understanding of the potential beneficial clinical effects, adverse effects and management strategies for patients experiencing toxicity or adverse effects of therapeutic psychoactive agents.
  3. Address societal implications of using therapeutic psychoactive agents.

Registration Rates

Rate DescriptionRate
ASAM Member$29
Non-Member$39
Associate Member$19
Resident Member*$19
Student Member*$19

*Residents, Fellows-in-training, Interns, and Students must join ASAM to receive a discounted registration rate. Click here to become an ASAM member. National and Chapter membership dues apply. There is no charge for Students to become a Member, but verification of student status is required.

Membership Question?  Call ASAM at 1.301.656.3920, email us, or view the ASAM website for more information.

Refunds & Cancellations

All ASAM eLearning Center refund requests must be made in writing to education@asam.org within 90 days of purchase. Those requesting refunds for courses that are in progress will receive partial refunds or e-Learning Center credit. Automatic full refunds will be made for any course with a live-course component that has been cancelled.

Registration Open: 05/06/2024 - 04/06/2027

User Access Closed: 05/06/2027

Session Instructions

  1. Click on the Contents tab to watch the on-demand recording.
  2. Click Complete Post Test to answer multiple choice questions. Participants will have 10 attempts to pass and must answer 4 out of 5 questions correctly.
  3. Click Complete Evaluation to provide valuable activity feedback. Scroll down on all questions as there may be answer options that expand past the size of the window.
  4. Click the button Claim Medical Credits in the box titled Claim Credits & Certificate. Choose the type of credit and click submit. Click the button View/Print Certificate to save or print your certificate. You can view/print your certificate at any time by visiting the ASAM eLearning Center, clicking Dashboard, and clicking Transcript/Achievements.

Need Assistance?

For assistance logging in, accessing activities, claiming credit, or for other questions or concerns, please check the FAQ page or e-mail Education@ASAM.org

ASAM is proud to offer Essential Accessibility to ensure our website is accessible and functional for all our learners while providing free assistive technology for people with the widest possible range of abilities.

JoAn Laes

MD

JoAn Laes, MD is an addiction medicine physician and consulting medical toxicologist. Her focus is inpatient addiction medicine and toxicology consultation, and outpatient treatment of opioid and other substance use disorders. She is an owner at Twin Cities Toxicology, providing consultation, medical directorship, and expert opinion in the fields of addiction medicine and medical toxicology. She is board-certified in Internal Medicine, Addiction Medicine, and Medical Toxicology. She completed an internal medicine residency at Hennepin County Medical Center and medical toxicology fellowship at Regions Hospital in St. Paul, Minnesota. She has spoken nationally on the subjects of addiction medicine and toxicology.

No relevant financial relationships

Ian Latham, MD

Addiction Medicine Fellow

Univeristy of Minnesota

Ian Latham, MD is an Addiction Medicine Fellow at the University of Minnesota; he recently completed his residency in Family Medicine at the University of Minnesota / North Memorial residency program. He completed his undergraduate education in Molecular Biology at the University of Wisconsin – Madison and his medical education at the Lewis Katz School of Medicine at Temple University in Philadelphia, Pennsylvania where he participated in research in Narrative Medicine, trauma-informed addiction care, and mobile services for buprenorphine treatment. Ian has a particular interest in working with patients who identify within the LGBTQ+ community, the management of behavioral addictions, and the treatment and prevention of viral disease among people living with addiction.

Evan S. Schwarz

MD

Dr. Evan Schwarz is an Associate Professor of Emergency Medicine and the Medical Toxicology Section Chief at the Washington University School of Medicine. Additionally, he is board certified in Addiction Medicine. He directs the medical toxicology and addiction medicine consultation service as well as their outpatient clinic and organized the Emergency Department buprenorphine treatment program. In addition to his work responsibilites, he is a member of the board of directors for the American College of Medical Toxicology and the President of the Missouri College of Emergency Physicians. He was appointed to the Opioid Advisory Committee through Missouri HealthNet and the Department of Social Services and is a physician consultant for Missouri’s State Targeted Response. 

Jeremiah D. Fairbanks

DO

Jeremiah Fairbanks, DO is a current addiction medicine fellow at the University of Minnesota. He completed his medical training at Des Moines University followed by a family medicine residency through the University of Minnesota. He has helped develop programs treating office based opioid use disorder through primary care in southern Minnesota and has his family medicine board certification. 

Robert Pueringer

MD

Robert "Cole" Pueringer, MD, CTropMed: I am an Internist/Hospitalist, Medical Toxicologist, and currently an Addiction Medicine Fellow at the University of Minnesota. Originally from Montana but all my medical training has been in the Minnesota. I completed Medical School at the University of Minnesota Twin Cities (2015), Internal Medicine Residency at Hennepin County Medical Center (Hennepin Healthcare) (2018), and a Medical Toxicology Fellowship at HealthPartners Institute/HCMC (2021). Interists include the overlap of Toxicology Addiction, Global Health, and SUD in healthcare professionals. I enjoy ourdoor recreation, soccer, and engagement in the recovery community.

Accreditation & Credit Designation Statements

Joint Accreditation Statement
image

In support of improving patient care, the American Society of Addiction Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians

The American Society of Addiction Medicine designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses

This activity awards 1.25 Nursing contact hours.

image
PAs

ASAM has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.25 AAPA Category 1 CME credits. Approval is valid until 05/06/2027.  PAs should only claim credit commensurate with the extent of their participation.

Social Workers

As a Jointly Accredited Organization, ASAM is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. Regulatory boards are the final authority on courses accepted for continuing education credit. Social workers completing this course receive 1.25 general continuing education credits.

IPCE Credit

This activity was planned by and for the healthcare team, and learners will receive 1.25 Interprofessional Continuing Education (IPCE) credits for learning and change.

California Association for Drug/Alcohol Educators (CAADE)

This educational program is approved by CAADE: #CP40 999 1225.

California Association of DUI Treatment Centers (CADTP)

This educational program is approved by CADTP: #205.

California Consortium of Addiction Programs and Professionals (CCAPP)

This educational program is approved by CCAPP: #OS-20-330-1224.

Continuing Education Credits (CEUs)

Upon completion of the activity and online evaluation, all other participants may request a certificate of participation. Participants may submit this certificate of participation to their professional organization/institute as documentation for completing this accredited continuing activity.

Maintenance of Certification (MOC) or Continuing Certification Programs (CCP)

This activity meets the requirements for MOC/CCP for the following primary physician boards and for state licensing CME requirements. MOC Credit is only reported for ABA, ABP, ABIM, and ABS. By completing the online credit application and evaluation, the learner permits ASAM to report credits to the appropriate Board. Learn more.

  • American Board of Medical Specialties (ABMS)
  • American Board of Preventive Medicine (ABPM)
  • American Board of Internal Medicine (ABIM)
  • American Board of Pediatrics (ABP)
  • American Board of Surgery (ABS)
  • American Board of Psychiatry and Neurology (ABPN)
  • American Board of Addiction Medicine (ABAM)
  • Royal College of Physicians and Surgeons of Canada (RCPSC)
    • Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons in Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.

Disclosure Information

In accordance with disclosure policies of ASAM and Joint Accreditation, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all CME/CE activities. These policies include mitigating all relevant financial relationships with ineligible companies for the Planning Committees and Presenters. All activity Planning Committee members and Presenters have disclosed all financial relationship information. The ASAM CE Committee has reviewed these disclosures and determined that the relationships are not inappropriate in the context of their respective presentations and are not inconsistent with the educational goals and integrity of the activity. Click here to view the full disclosure listing.

Key:

Complete
Failed
Available
Locked
View On-Demand Recording
Open to view video.  |   Closed captions available
Open to view video.  |   Closed captions available Video is approximately 75 minutes long. Recorded between 04/04/24 - 04/07/24.
Complete Post Test
5 Questions  |  10 attempts  |  4/5 points to pass
5 Questions  |  10 attempts  |  4/5 points to pass This post-test has 5 questions and requires 4 out of 5 to pass the quiz.
Complete Evaluation
15 Questions
15 Questions Scroll down on evaluation, there may be questions that expand past the size of the window.
Claim Credit & Certificate
Up to 1.25 medical credits available  |  Certificate available
Up to 1.25 medical credits available  |  Certificate available Attendees should claim only the credit commensurate with the extent of their participation in the activity.